1 March 2023 false No description of principal activity Taxfiler 2024.5 13886990business:PrivateLimitedCompanyLtd2023-03-012024-02-29 138869902023-02-28 138869902023-03-012024-02-29 13886990business:AuditExemptWithAccountantsReport2023-03-012024-02-29 13886990business:FilletedAccounts2023-03-012024-02-29 138869902024-02-29 13886990business:Director12023-03-012024-02-29 13886990business:RegisteredOffice2023-03-012024-02-29 138869902023-02-28 13886990core:WithinOneYear2024-02-29 13886990core:WithinOneYear2023-02-28 13886990core:AfterOneYear2024-02-29 13886990core:AfterOneYear2023-02-28 13886990core:ShareCapitalcore:PreviouslyStatedAmount2024-02-29 13886990core:ShareCapitalcore:PreviouslyStatedAmount2023-02-28 13886990core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-02-29 13886990core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-02-28 13886990core:PreviouslyStatedAmount2024-02-29 13886990core:PreviouslyStatedAmount2023-02-28 13886990business:SmallEntities2023-03-012024-02-29 13886990countries:EnglandWales2023-03-012024-02-29 13886990core:MotorVehicles2023-03-012024-02-29 13886990core:FurnitureFittings2023-03-012024-02-29 13886990core:MotorVehicles2023-02-28 13886990core:FurnitureFittings2023-02-28 13886990core:MotorVehicles2024-02-29 13886990core:FurnitureFittings2024-02-29 138869902022-02-022023-02-28 iso4217:GBP xbrli:pure
Company Registration No. 13886990 (England and Wales)
CRYSTAL PHARMA LIMITED Unaudited accounts for the year ended 29 February 2024
CRYSTAL PHARMA LIMITED Unaudited accounts Contents
Page
- 2 -
CRYSTAL PHARMA LIMITED Company Information for the year ended 29 February 2024
Director
Majid Ayub
Company Number
13886990 (England and Wales)
Registered Office
94 CARK ROAD KEIGHLEY BD21 3BH ENGLAND
Accountants
iTax Accountants ® 241 Manningham Lane Bradford West Yorkshire BD8 7ER
- 3 -
CRYSTAL PHARMA LIMITED Statement of financial position as at 29 February 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Tangible assets
71,828 
8,000 
Current assets
Inventories
35,000 
210,000 
Debtors
98,635 
37,515 
Cash at bank and in hand
597,944 
20,235 
731,579 
267,750 
Creditors: amounts falling due within one year
(649,981)
(264,538)
Net current assets
81,598 
3,212 
Total assets less current liabilities
153,426 
11,212 
Creditors: amounts falling due after more than one year
(36,052)
- 
Net assets
117,374 
11,212 
Capital and reserves
Called up share capital
1 
1 
Profit and loss account
117,373 
11,211 
Shareholders' funds
117,374 
11,212 
For the year ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 25 September 2024 and were signed on its behalf by
Majid Ayub Director Company Registration No. 13886990
- 4 -
CRYSTAL PHARMA LIMITED Notes to the Accounts for the year ended 29 February 2024
1
Statutory information
CRYSTAL PHARMA LIMITED is a private company, limited by shares, registered in England and Wales, registration number 13886990. The registered office is 94 CARK ROAD, KEIGHLEY, BD21 3BH, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Motor vehicles
20% RB Apportioned
Fixtures & fittings
20% RB
4
Tangible fixed assets
Motor vehicles 
Fixtures & fittings 
Total 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At 1 March 2023
- 
10,000 
10,000 
Additions
74,069 
- 
74,069 
At 29 February 2024
74,069 
10,000 
84,069 
Depreciation
At 1 March 2023
- 
2,000 
2,000 
Charge for the year
8,641 
1,600 
10,241 
At 29 February 2024
8,641 
3,600 
12,241 
Net book value
At 29 February 2024
65,428 
6,400 
71,828 
At 28 February 2023
- 
8,000 
8,000 
5
Debtors
2024 
2023 
£ 
£ 
Amounts falling due within one year
VAT
98,635 
37,515 
- 5 -
CRYSTAL PHARMA LIMITED Notes to the Accounts for the year ended 29 February 2024
6
Creditors: amounts falling due within one year
2024 
2023 
£ 
£ 
Bank loans and overdrafts
16,412 
- 
Trade creditors
388,435 
86,892 
Taxes and social security
45,735 
2,651 
Other creditors
2,662 
- 
Loans from directors
196,737 
174,995 
649,981 
264,538 
7
Creditors: amounts falling due after more than one year
2024 
2023 
£ 
£ 
Obligations under finance leases and hire purchase contracts
36,052 
- 
8
Average number of employees
During the year the average number of employees was 1 (2023: 1).
- 6 -